» Articles » PMID: 29049756

Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review

Overview
Journal Ann Intern Med
Specialty General Medicine
Date 2017 Oct 20
PMID 29049756
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Fecal immunochemical testing is the most commonly used method for colorectal cancer screening worldwide. However, its effectiveness is frequently undermined by failure to obtain follow-up colonoscopy after positive test results.

Purpose: To evaluate interventions to improve rates of follow-up colonoscopy for adults after a positive result on a fecal test (guaiac or immunochemical).

Data Sources: English-language studies from the Cochrane Central Register of Controlled Trials, PubMed, and Embase from database inception through June 2017.

Study Selection: Randomized and nonrandomized studies reporting an intervention for colonoscopy follow-up of asymptomatic adults with positive fecal test results.

Data Extraction: Two reviewers independently extracted data and ranked study quality; 2 rated overall strength of evidence for each category of study type.

Data Synthesis: Twenty-three studies were eligible for analysis, including 7 randomized and 16 nonrandomized studies. Three were at low risk of bias. Eleven studies described patient-level interventions (changes to invitation, provision of results or follow-up appointments, and patient navigators), 5 provider-level interventions (reminders or performance data), and 7 system-level interventions (automated referral, precolonoscopy telephone calls, patient registries, and quality improvement efforts). Moderate evidence supported patient navigators and provider reminders or performance data. Evidence for system-level interventions was low. Seventeen studies reported the proportion of test-positive patients who completed colonoscopy compared with a control population, with absolute differences of -7.4 percentage points (95% CI, -19 to 4.3 percentage points) to 25 percentage points (CI, 14 to 35 percentage points).

Limitation: More than half of studies were at high or very high risk of bias; heterogeneous study designs and characteristics precluded meta-analysis.

Conclusion: Patient navigators and giving providers reminders or performance data may help improve colonoscopy rates of asymptomatic adults with positive fecal blood test results. Current evidence about useful system-level interventions is scant and insufficient.

Primary Funding Source: National Cancer Institute. (PROSPERO: CRD42016048286).

Citing Articles

Impact of the COVID-19 pandemic on adherence to diagnostic colonoscopy after a positive non-invasive screening test for colorectal cancer in two Indiana healthcare systems.

Richter B, Roth S, Golzarri-Arroyo L, Kumar V, Tuason R, Imperiale T Prev Med Rep. 2024; 49:102937.

PMID: 39691357 PMC: 11648236. DOI: 10.1016/j.pmedr.2024.102937.


Added Value of Medical Subject Headings Terms in Search Strategies of Systematic Reviews: Comparative Study.

Leblanc V, Hamroun A, Bentegeac R, Le Guellec B, Lenain R, Chazard E J Med Internet Res. 2024; 26:e53781.

PMID: 39561364 PMC: 11615561. DOI: 10.2196/53781.


Optimizing tracking and completion of follow-up colonoscopy after abnormal stool tests at health systems participating in the Centers for Disease Control and Prevention's Colorectal Cancer Control Program.

Subramanian S, Tangka F, Hoover S, Mathews A, Redwood D, Smayda L Cancer Causes Control. 2024; 35(11):1467-1476.

PMID: 39107449 PMC: 11670815. DOI: 10.1007/s10552-024-01898-w.


Impact of racial disparities in follow-up and quality of colonoscopy on colorectal cancer outcomes.

Alagoz O, May F, Doubeni C, Fendrick A, Vahdat V, Estes C J Natl Cancer Inst. 2024; 116(11):1807-1816.

PMID: 39044335 PMC: 11542987. DOI: 10.1093/jnci/djae140.


Perceptions of the Impact of Comorbidity on the Bowel Cancer Screening Programme: Qualitative Study With Bowel Screening Participants and Staff.

Price D, Brain K, Dolwani S, Edwards A, Hood K, Smits S Health Expect. 2024; 27(4):e14126.

PMID: 38952213 PMC: 11217598. DOI: 10.1111/hex.14126.


References
1.
Van Kleek E, Liu S, Conn L, Hoadley A, Ho S . Improving the effectiveness of fecal occult blood testing in a primary care clinic by direct colonoscopy referral for positive tests. J Healthc Qual. 2010; 32(6):62-9. DOI: 10.1111/j.1945-1474.2009.00071.x. View

2.
Paterson W, Depew W, Pare P, Petrunia D, Switzer C, Veldhuyzen van Zanten S . Canadian consensus on medically acceptable wait times for digestive health care. Can J Gastroenterol. 2006; 20(6):411-23. PMC: 2659924. DOI: 10.1155/2006/343686. View

3.
Raich P, Whitley E, Thorland W, Valverde P, Fairclough D . Patient navigation improves cancer diagnostic resolution: an individually randomized clinical trial in an underserved population. Cancer Epidemiol Biomarkers Prev. 2012; 21(10):1629-38. PMC: 4053249. DOI: 10.1158/1055-9965.EPI-12-0513. View

4.
Carlson C, Kirby K, Casadei M, Partin M, Kistler C, Walter L . Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?. Arch Intern Med. 2010; 171(3):249-56. PMC: 3021762. DOI: 10.1001/archinternmed.2010.372. View

5.
. Cancer screening - United States, 2010. MMWR Morb Mortal Wkly Rep. 2012; 61(3):41-5. View